Advertisement

St. Jude Medical says it's enrolled the 1st patient in the Ilumien I clinical trial of its PressureWire Aeris fractional flow reserve device.

St. Jude Medical

St. Jude Medical (NYSE:STJ) said the Ilumien I clinical trial of its PressureWire Aeris fractional flow reserve device is under way, with the 1st of 500 patients enrolled.

The study aims to show the best way to use optical coherence tomography during coronary angiography procedures using the PressureWire Aeris.

The device uses a sensor to measure arterial blood pressure by calculating fractional flow reserve associated with stenosis in patients with coronary artery disease.

Advertisement
Advertisement